Campbell, CA, United States of America

Relign Corporation


USPTO Granted Patents = 70


Trademarks = 2

Forward Citations = 721

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Aaron Germain (70 out of 163 patents)

silverMedal Michael D Walker (22 out of 83 patents)

bronzeMedal Kyle Klein (20 out of 72 patents)

4 Jan M Echeverry (19 out of 53 patents)

5 Jeff Norton (16 out of 16 patents)

6 Steffan A Benamou (15 out of 23 patents)

7 Benedek Orczy-Timko (9 out of 48 patents)

8 Simon Malkevich (8 out of 8 patents)

9 Jacob Tonkel (8 out of 8 patents)

10 Ben Poser (7 out of 7 patents)

11 Balazs Lesko (7 out of 24 patents)

12 Jeffrey Norton (7 out of 8 patents)

13 Evan Nessim (6 out of 6 patents)

14 Salvatore G Mangano (4 out of 4 patents)

15 Sal Mangano (3 out of 3 patents)


Core Competencies:
Arthroscopy
Medical Ablation
Surgical Techniques
Minimally Invasive
Endoscopic Devices
Surgical Instruments
Tissue Ablation
Joint Surgery
Medical Devices
Orthopedic Surgery
Diagnostic Tools
Therapeutic Applications

70 patents:

Relign Corporation is a leading provider of innovative solutions for the automotive industry. With a focus on developing advanced technologies, we specialize in the design, manufacturing, and distribution of high-quality automotive components. Our products are renowned for their durability, performance, and reliability. As a customer-oriented company, we strive to deliver exceptional products and services that meet the unique requirements of our clients. Visit our website to learn more about our extensive product range and how we can contribute to enhancing your automotive business.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Relign Corporation
70 Patents

#10 in Campbell, CA

#1,220 in California

#5,223 in US

#10,605 in the World

Campbell, CA (US)
Campbell, CA, United States of America
Forward Citations = 721

17 inventors:

Please report any incorrect information to [email protected]
Loading…